Chlorhexidine antisepsis significantly reduces the incidence of sepsis and septicemia during parenteral nutrition in surgical infants

Journal of Pediatric Surgery

Volumn 46, Issue 6, 2011, Pages 1064-1069

  Bishay, Mark ^a   Retrosi, Giuseppe ^a   Horn, Venetia ^b   Cloutman Green, Elaine ^b   Harris, Kathryn ^b   De Coppi, Paolo ^a   Klein, Nigel ^a   Eaton, Simon ^a   Pierro, Agostino ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Central venous catheter; Gastroschisis; Infection; Necrotizing enterocolitis; Neonatal intestinal obstruction; Neonates

Indexed keywords

2 PROPANOL; CHLORHEXIDINE;

ANTISEPSIS; ARTICLE; BLOOD CULTURE; CATHETER CARE; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; GASTROINTESTINAL SURGERY; HUMAN; INFANT; MAJOR CLINICAL STUDY; PARENTERAL NUTRITION; PRIORITY JOURNAL; SEPSIS; SEPTICEMIA; SURGICAL PATIENT;

EID: 79959311560     PISSN: 00223468     EISSN: 15315037     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2011.03.028     Document Type: Article

References (13)

1. Donnell SC, Taylor N, van Saene HK, et al. Infection rates in surgical neonates and infants receiving parenteral nutrition: a five-year prospective study. J Hosp Infect 2002;52:273-80. (Pubitemid 38001908)
2. Soothill JS, Bravery K, Ho A, et al. A fall in bloodstream infections followed a change to 2% chlorhexidine in 70% isopropanol for catheter connection antisepsis: a pediatric single center before/after study on a hemopoietic stem cell transplant ward. Am J Infect Control 2009;37:626-30.
3. Edwards JR, Peterson KD, Mu Y, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009;37:783-805.
4. Elward AM, Hollenbeak CS, Warren DK, et al. Attributable cost of nosocomial primary bloodstream infection in pediatric intensive care unit patients. Pediatrics 2005;115:868-72.
5. Dominguez TE, Chalom R, Costarino Jr AT. The impact of adverse patient occurrences on hospital costs in the pediatric intensive care unit. Crit Care Med 2001;29:169-74. (Pubitemid 32125793)
6. Slonim AD, Singh N. Nosocomial bloodstream infection and cost. Crit Care Med 2001;29:1849.
7. Holmes A, Dore CJ, Saraswatula A, et al. Risk factors and recommendations for rate stratification for surveillance of neonatal healthcare - associated bloodstream infection. J Hosp Infect 2008;68:66-72.
8. Pichler J, Horn V, Macdonald S, et al. Sepsis and its etiology among hospitalized children less than 1 year of age with intestinal failure on parenteral nutrition. Transplant Proc 2010;42:24-5.
9. Kuyyakanond T, Quesnel LB. The mechanism of action of chlorhexidine. FEMS Microbiol Lett 1992;79:211-5. (Pubitemid 23008524)
10. Pratt RJ, Pellowe CM, Wilson JA, et al. epic2: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England. J Hosp Infect 2007;65(Suppl 1):S1-S64.
11. Garland JS, Henrickson K, Maki DG. The 2002 Hospital Infection Control Practices Advisory Committee Centers for Disease Control and Prevention guideline for prevention of intravascular device-related infection. Pediatrics 2002;110:1009-13.
12. Bhutta A, Gilliam C, Honeycutt M, et al. Reduction of bloodstream infections associated with catheters in paediatric intensive care unit: stepwise approach. BMJ 2007;334:362-5. (Pubitemid 46328049)
13. Garland JS, Alex CP, Mueller CD, et al. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates. Pediatrics 2001;107:1431-6.